Diadema Partners LP Options Holdings

Diadema Partners LP

  • $233 Billion
  • Q4 2024

Options Holdings Table

Stock Option Type Value Options Held Last Trade Trade History
VRTX
Vertex Pharmaceuticals Inc

Healthcare
CALL
$23.1 Billion
57.4K
Q4 2024
New holding
XBI
Spdr Ser Tr Spdr S&P Biotech E

ETFs
PUT
$18 Billion
200K
Q4 2024
New holding
ABBV
Abb Vie Inc.

Healthcare
PUT
$8.89 Billion
50K
Q4 2024
New holding
Soleno Therapeutics Inc
PUT
$7.88 Billion
175K
Q4 2024
New holding
ACLX
Arcellx, Inc.

Healthcare
PUT
$7.67 Billion
100K
Q4 2024
New holding
CRSP
Crispr Therapeutics Ag

Healthcare
CALL
$7.51 Billion
191K
Q4 2024
New holding
TGTX
Tg Therapeutics, Inc.

Healthcare
PUT
$6.02 Billion
200K
Q4 2024
New holding
HALO
Halozyme Therapeutics, Inc.

Healthcare
CALL
$4.78 Billion
100K
Q4 2024
New holding
RARE
Ultragenyx Pharmaceutical Inc.

Healthcare
PUT
$4.44 Billion
106K
Q4 2024
New holding
Soleno Therapeutics Inc
CALL
$4.25 Billion
94.6K
Q4 2024
New holding
ITCI
Intra Cellular Therapies, Inc.

Healthcare
CALL
$3.65 Billion
43.7K
Q4 2024
New holding
INSM
Insmed Inc

Healthcare
CALL
$3.45 Billion
50K
Q4 2024
New holding
AGIO
Agios Pharmaceuticals, Inc.

Healthcare
CALL
$3.35 Billion
102K
Q4 2024
New holding
APLS
Apellis Pharmaceuticals, Inc.

Healthcare
CALL
$3.19 Billion
100K
Q4 2024
New holding
Anaptysbio Inc
CALL
$2.85 Billion
215K
Q4 2024
New holding
BBIO
Bridge Bio Pharma, Inc.

Healthcare
CALL
$2.74 Billion
100K
Q4 2024
New holding
CAPR
Capricor Therapeutics, Inc.

Healthcare
CALL
$2.76 Billion
200K
Q4 2024
New holding
CLDX
Celldex Therapeutics, Inc.

Healthcare
CALL
$2.53 Billion
100K
Q4 2024
New holding
RARE
Ultragenyx Pharmaceutical Inc.

Healthcare
CALL
$2.2 Billion
52.3K
Q4 2024
New holding
KROS
Keros Therapeutics, Inc.

Healthcare
CALL
$2.06 Billion
130K
Q4 2024
New holding
RXRX
Recursion Pharmaceuticals, Inc.

Healthcare
CALL
$2.03 Billion
300K
Q4 2024
New holding
SRRK
Scholar Rock Holding Corp

Healthcare
CALL
$1.86 Billion
43K
Q4 2024
New holding
QURE
Uni Qure N.V.

Healthcare
CALL
$1.77 Billion
100K
Q4 2024
New holding
ALT
Altimmune, Inc.

Healthcare
CALL
$1.44 Billion
200K
Q4 2024
New holding
Anaptysbio Inc
PUT
$1.32 Billion
100K
Q4 2024
New holding
JANX
Janux Therapeutics, Inc.

Healthcare
PUT
$937 Million
17.5K
Q4 2024
New holding
FOLD
Amicus Therapeutics, Inc.

Healthcare
CALL
$942 Million
100K
Q4 2024
New holding
SAVA
Cassava Sciences Inc

Healthcare
PUT
$876 Million
371K
Q4 2024
New holding
OCUL
Ocular Therapeutix, Inc

Healthcare
CALL
$888 Million
104K
Q4 2024
New holding
Neumora Therapeutics Inc.
CALL
$861 Million
81.2K
Q4 2024
New holding
CAPR
Capricor Therapeutics, Inc.

Healthcare
PUT
$810 Million
58.7K
Q4 2024
New holding
KROS
Keros Therapeutics, Inc.

Healthcare
PUT
$798 Million
50.4K
Q4 2024
New holding
IOVA
Iovance Biotherapeutics, Inc.

Healthcare
CALL
$740 Million
100K
Q4 2024
New holding
VIR
Vir Biotechnology, Inc.

Healthcare
CALL
$734 Million
100K
Q4 2024
New holding
AVTE
Aerovate Therapeutics, Inc.

Healthcare
PUT
$508 Million
192K
Q4 2024
New holding
RLAY
Relay Therapeutics, Inc.

Healthcare
CALL
$412 Million
100K
Q4 2024
New holding
SMMT
Summit Therapeutics Inc.

Healthcare
CALL
$357 Million
20K
Q4 2024
New holding
WAVE
Eco Wave Power Global Ab (Publ)
CALL
$292 Million
23.6K
Q4 2024
New holding
CCCC
C4 Therapeutics, Inc.

Healthcare
CALL
$288 Million
80.1K
Q4 2024
New holding
BMEA
Biomea Fusion, Inc.

Healthcare
PUT
$277 Million
71.4K
Q4 2024
New holding
CADL
Candel Therapeutics, Inc.

Healthcare
PUT
$286 Million
32.9K
Q4 2024
New holding
GOSS
Gossamer Bio, Inc.

Healthcare
CALL
$232 Million
257K
Q4 2024
New holding
SMMT
Summit Therapeutics Inc.

Healthcare
PUT
$152 Million
8.5K
Q4 2024
New holding
Q32 Bio Inc
PUT
$121 Million
35.1K
Q4 2024
New holding
KOD
Kodiak Sciences Inc.

Healthcare
CALL
$72.6 Million
7.3K
Q4 2024
New holding
LRMR
Larimar Therapeutics, Inc.

Healthcare
PUT
$65.4 Million
16.9K
Q4 2024
New holding
ALXO
Alx Oncology Holdings Inc

Healthcare
CALL
$65 Million
38.9K
Q4 2024
New holding
ARVN
Arvinas, Inc.

Healthcare
PUT
$44.1 Million
2.3K
Q4 2024
New holding
Q32 Bio Inc
CALL
$19.3 Million
5.6K
Q4 2024
New holding

Summary

  • Portfolio
  • No. of Stocks 107
  • Current Value $233 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 54 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Diadema Partners LP Portfolio

Follow Diadema Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diadema Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Diadema Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email